Transforming the future of radiation oncology: Three ways collaboration accelerates FLASH radiation therapy research

Temozolomide + radiation treatment improves OS for grade 2 gliomas

Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.

December 06, 2024

Vol.50 No.45

In Brief

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

Luca Valle, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA, was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.

October 25, 2024

Vol.50 No.40

Clinical Roundup

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

The American Society for Radiation Oncology published an updated clinical guideline in Practical Radiation Oncology that details best practices for using radiation therapy to treat patients who have oropharyngeal squamous cell carcinoma caused by the human papilloma virus.

June 21, 2024

Vol.50 No.25

Clinical Roundup

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Cosylab, a provider of control systems and software solutions for complex and precise machines, has entered into a collaboration with Mayo Clinic to advance cancer care in the United States and beyond.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

Researchers at MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction surgery, which reduced the number of operations required, minimized treatment delays, and improved patient satisfaction.

April 12, 2024

Vol.50 No.15

Clinical Roundup

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center showed that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.

January 19, 2024

Vol.50 No.03

Transforming the future of radiation oncology:

Three ways collaboration accelerates FLASH radiation therapy research

YOU MAY BE INTERESTED IN

Temozolomide + radiation treatment improves OS for grade 2 gliomas

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

Renew today!

Subscriber content

Never miss an issue!

Login